Regenxbio submits $300M mixed shelf registration statement
Written by Ohris M. Greyoon, Blockchain & Crypto Expert
Source: SeekingAlpha
Updated: Nov 26 2025Shelf Registration Filing: Regenxbio (RGNX) has filed a shelf registration to offer up to $300 million in various securities, including common stock, preferred stock, and debt securities.
Pipeline Developments: The company is advancing its late-stage pipeline, with plans to release top-line data for RGX-202 in Duchenne muscular dystrophy in early Q2 2026 and aims for a commercial launch in 2027.
About the author
Ohris M. Greyoon
Ohris M. Greyoon holds a Master’s in Computer Science from MIT and has 10 years of experience in blockchain technology and cryptocurrency markets. A pioneer in decentralized finance (DeFi) analysis, he leads Intellectia’s Crypto News, offering cutting-edge insights into digital assets.
